INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/05/2026
Back to search
Official data from USPTO
MAILPAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MAILPAN
ST13
US500000079210812Class
5, 10, 42
Filing
79210812
Registration
5494493
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/06/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
01/09/2017
Registration date
06/19/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/03/2025
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
RIRIE, VERNA BETH
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DEFYMED
Representatives
ANDREW W. CHU AND L. JEREMY CRAFT CRAFT CHU PLLC
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human and animal cells for medical use; stem cells for medical or veterinary use; cultures of microorganisms for medical or veterinary use; biological tissue cultures for medical or veterinary use; enzymes for medical or veterinary use; vascular grafts of living tissues; hormones for medical use; surgical implants composed of living tissue; medicines for intestinal disorders in humans; biological preparations for medical or veterinary use in treating metabolic disorders; chemical-pharmaceutical preparations for the treatment of diabetes; chemical preparations for medical or veterinary use for the treatment of diabetes; chemical preparations for pharmaceutical use in the treatment of diabetes; preparations of microorganisms for medical and veterinary use in the treatment of diabetes; diagnostic preparations for medical or veterinary use
Class 10
Surgical and medical apparatus and instruments for use in implanting insulin injectors; catheters; implantable devices for the subcutaneous release of medicated substances sold empty; surgical implants comprised of artificial materials; vacuum pumps for medical use; injector devices for medical use in delivering pharmaceuticals
Class 42
Conducting clinical trials for others in the fields of medical devices and pharmaceuticals; research and development of new products for others; research and development in the field of bioartificial medical devices; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; biological research services; bacteriological research services; chemical research; scientific research; technical research in the field of pharmaceutical studies; services provided by consultants relating to scientific research and development in the field of therapeutics; scientific laboratory services
Publications
History of USPTO decisions and trademark events.
34 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/16/2026
INPC
INVALIDATION PROCESSED
02/16/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/10/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/03/2025
C71T
CANCELLED SECTION 71
01/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/19/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/12/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/22/2018
FIMP
FINAL DISPOSITION PROCESSED
09/22/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/19/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/19/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2018
PUBO
PUBLISHED FOR OPPOSITION
04/03/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/30/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/14/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/14/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2018
ALIE
ASSIGNED TO LIE
01/25/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2018
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/15/2017
RFRR
REFUSAL PROCESSED BY MPU
07/15/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/08/2017
CNRT
NON-FINAL ACTION WRITTEN
07/07/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/04/2017
DOCK
ASSIGNED TO EXAMINER
06/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/30/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/29/2017
Continuous trademark protection
Get notified about every new filing that threatens MAILPAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.